Pay in 4 interest-free payments of $5.19 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Following high-profile reports in 2024 of an elevated risk of nonarteritic anterior ischemic optic neuropathy (NAION) in type 2 diabetes patients taking glucagonlike peptide-1 (GLP-1) receptor agonists seen at one facility (Massachusetts Eye and Ear), there remains a need to clarify the potential risk of ophthalmic complications from semaglutide exposure using multicenter data
Nat Med 27(11):19541960 Alexiadou K, Hartley A, Tan TMM, Khamis R (2024) The cardiovascular effects of GLP-1 receptor agonists beyond obesity and type 2 diabetes: an anti-atherosclerotic action
Key ingredients like Vitamin C promote collagen production, which helps improve skin elasticity and reduce wrinkles
Most patients start with weekly injections, though some may move to longer intervals depending on their response
